%0 Journal Article
%T Evidence-based clinical practice guidelines for management of colorectal polyps.
%A Tanaka S
%A Saitoh Y
%A Matsuda T
%A Igarashi M
%A Matsumoto T
%A Iwao Y
%A Suzuki Y
%A Nozaki R
%A Sugai T
%A Oka S
%A Itabashi M
%A Sugihara KI
%A Tsuruta O
%A Hirata I
%A Nishida H
%A Miwa H
%A Enomoto N
%A Shimosegawa T
%A Koike K
%J J Gastroenterol
%V 56
%N 4
%D 04 2021
%M 33710392
%F 6.772
%R 10.1007/s00535-021-01776-1
%X The Japanese Society of Gastroenterology (JSGE) published ''Daicho Polyp Shinryo Guideline 2014'' in Japanese and a part of this guideline was published in English as "Evidence-based clinical practice guidelines for management of colorectal polyps" in the Journal of Gastroenterology in 2015. A revised version of the Japanese-language guideline was published in 2020, and here we introduce a part of the contents of revised version.
The guideline committee discussed and drew up a series of clinical questions (CQs). Recommendation statements for the CQs were limited to items with multiple therapeutic options. Items with established conclusions that had 100% agreement with previous guidelines (background questions) and items with no (or old) evidence that are topics for future research (future research questions: FRQs) were given descriptions only. To address the CQs and FRQs, PubMed, ICHUSHI, and other sources were searched for relevant articles published in English from 1983 to October 2018 and articles published in Japanese from 1983 to November 2018. The Japan Medical Library Association was also commissioned to search for relevant materials. Manual searches were performed for questions with insufficient online references.
The professional committee created 18 CQs and statements concerning the current concept and diagnosis/treatment of various colorectal polyps, including their epidemiology, screening, pathophysiology, definition and classification, diagnosis, management, practical treatment, complications, and surveillance after treatment, and other colorectal lesions (submucosal tumors, nonneoplastic polyps, polyposis, hereditary tumors, ulcerative colitis-associated tumors/carcinomas).
After evaluation by the moderators, evidence-based clinical practice guidelines for management of colorectal polyps were proposed for 2020. This report addresses the therapeutic related CQs introduced when formulating these guidelines.